This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Agenus Reports Fourth Quarter And Year End 2012 Financial Results

Stimulon is a registered trademark of Agenus Inc. and its subsidiaries.

 
Summary Consolidated Financial Information
         
Condensed Consolidated Statements of Operations Data
(in thousands, except per share data)
(unaudited)
         
  Three months ended December 31, Year ended December 31,
  2012 2011 2012 2011
         
Revenue  $ 1,090  $ 644  $ 15,961  $ 2,756
         
Operating expenses:        
Cost of revenue  303  --   672  -- 
Research and development  2,371  2,856  10,565  11,023
General and administrative   2,645  2,710  11,465  10,820
         
Operating loss  (4,229)  (4,922)  (6,741)  (19,087)
         
Other expense, net  1,211  1,098  4,584  4,190
         
Net loss  (5,440)  (6,020)  (11,325)  (23,277)
         
Dividends on Series A convertible preferred stock  (199)  (197)  (792)  (790)
         
Net loss attributable to common stockholders  $ (5,639)  $ (6,217)  $ (12,117)  $ (24,067)
         
Per common share data, basic and diluted:        
Net loss attributable to common stockholders  $ (0.23)  $ (0.29)  $ (0.51)  $ (1.21)
Weighted average number of common shares outstanding, basic and diluted  24,682  21,519  23,629  19,899
         
         
Condensed Consolidated Balance Sheet Data
(in thousands)
(unaudited)
         
  December 31, 2012 December 31, 2011    
         
Cash and cash equivalents  $ 21,468  $ 10,748    
Total assets  29,093  19,808    
Total stockholders' deficit  (17,600)  (20,831)    
CONTACT: Media and Investors: 
         Jonae R. Barnes
         Vice President 
         Investor Relations &
         Corporate Communications
         617-818-2985

company logo

5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,799.01 -129.19 -0.72%
S&P 500 2,077.93 -11.53 -0.55%
NASDAQ 4,909.2630 -30.0640 -0.61%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs